Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M, Morimoto T, Nomura T, Michishita S, Nishimukai A, Higuchi T, Fujimoto Y, Miyagawa Y, Kira A, Murase K, Araki K, Takatsuka Y, Oh K, Masai Y, Akazawa K, Miyoshi Y. Imamura M, et al. World J Surg Oncol. 2018 Feb 12;16(1):26. doi: 10.1186/s12957-018-1325-6. World J Surg Oncol. 2018. PMID: 29433529 Free PMC article.
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A, Yagi T, Yanai A, Miyagawa Y, Enomoto Y, Murase K, Imamura M, Takatsuka Y, Sakita I, Hatada T, Miyoshi Y. Nishimukai A, et al. Among authors: imamura m. Clin Breast Cancer. 2015 Jun;15(3):204-11. doi: 10.1016/j.clbc.2014.12.007. Epub 2014 Dec 24. Clin Breast Cancer. 2015. PMID: 25600243
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Imamura M, Nishimukai A, Higuchi T, Ozawa H, Yanai A, Miyagawa Y, Murase K, Sakita I, Hatada T, Takatsuka Y, Katagiri T, Miyoshi Y. Imamura M, et al. Breast Cancer Res Treat. 2015 Dec;154(3):521-31. doi: 10.1007/s10549-015-3638-2. Epub 2015 Nov 16. Breast Cancer Res Treat. 2015. PMID: 26573829
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Higuchi T, Fujimoto Y, Ozawa H, Bun A, Fukui R, Miyagawa Y, Imamura M, Kitajima K, Yamakado K, Miyoshi Y. Higuchi T, et al. Among authors: imamura m. Ann Surg Oncol. 2019 Jul;26(7):2175-2183. doi: 10.1245/s10434-019-07325-8. Epub 2019 Apr 2. Ann Surg Oncol. 2019. PMID: 30941655 Free PMC article.
2,375 results